Hemispherx Biopharma Prevails in Multi-Million Dollar Federal Lawsuit
20 oct. 2014 08h30 HE
|
AIM ImmunoTech Inc.
PHILADELPHIA, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that a federal judge in Delaware has dismissed all claims...